Yüklüyor......

Enhancement in Specific CD8+ T cell Recognition of EphA2+ Tumors In Vitro and In Vivo After Treatment with Ligand Agonists()

The EphA2 receptor tyrosine kinase (RTK) is an attractive therapeutic target that is commonly overexpressed on solid tumors, with the degree of overexpression associated with disease progression, metastatic potential and poor prognosis. Agonistic monoclonal antibodies or ligand (ephrinA1)-Fc fusion...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Wesa, Amy K., Herrem, Christopher J., Mandic, Maja, Taylor, Jennifer L., Vasquez, Cecilia, Kawabe, Mayumi, Tatsumi, Tomohide, Leibowitz, Michael S., Finke, James H., Bukowski, Ronald M., Bruckheimer, Elizabeth, Kinch, Michael S., Storkus, Walter J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2008
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3427921/
https://ncbi.nlm.nih.gov/pubmed/19017961
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!